Bharathi Devarakonda

Bharathi Devarakonda

Senior Vice President of Regulatory Affairs &
Product Development

Bharathi Devarakonda is responsible for overseeing development and regulatory activities for all of Eton’s pipelines products.

Dr. Devarakonda has significant experience in the pharmaceutical product development and regulatory submission activities of both NDA and ANDA filings. She has worked in product development and regulatory affairs for a number of premier pharmaceutical companies, including Morton Grove Pharmaceuticals (acquired by Wockhardt), Akorn Inc, Hospira(acquired by Pfizer), Rockwell Medical,Inc., and Medefil, Inc.

During her career, she has filed more than 80 original NDA, ANDA, and ANADA applications with the FDA. Dr. Devarakonda has a Ph.D and M.S. in Pharmaceutics, a B.S. in Pharmacy, and has significant academic research experience in formulation development and drug delivery.

Bharathi Devarakonda

Bharathi Devarakonda

Senior Vice President of Regulatory Affairs &
Product Development

Bharathi Devarakonda is responsible for overseeing development and regulatory activities for all of Eton’s pipelines products.

Dr. Devarakonda has significant experience in the pharmaceutical product development and regulatory submission activities of both NDA and ANDA filings. She has worked in product development and regulatory affairs for a number of premier pharmaceutical companies, including Morton Grove Pharmaceuticals (acquired by Wockhardt), Akorn Inc, Hospira(acquired by Pfizer), Rockwell Medical,Inc., and Medefil, Inc.

During her career, she has filed more than 80 original NDA, ANDA, and ANADA applications with the FDA. Dr. Devarakonda has a Ph.D and M.S. in Pharmaceutics, a B.S. in Pharmacy, and has significant academic research experience in formulation development and drug delivery.